Institute of Good Manufacturing Practices India

Global accredited training & certification provider

IGMPI Approvals & Accreditation : Approved by Quality Council of India (QCI) & Accredited Vocational Institution of Ministry of HRD, Government of India, Approved Training Institute of Food Safety and Standards Authority of India (FSSAI), Recognized by Department of Industrial Policy & Promotion, Ministry of Commerce & Industry, Government of India, An ISO 9001:2015 Certified Organisation registered under The Societies Registration Act,1860 Government of India Empanelled under Ministry of Horticulture and Food Processing, Government of Uttar Pradesh, Affiliated with Life Sciences and Food Industry Sector Skills Council (SSC)
Trusted by organizations & training participants in over 30 countries. Training | Certification | Education | Research

First line Cholangiocarcinoma therapy announced by Incyte


04th June 2019

An open-label Phase III study for FIGHT-302 using pemigatinib (INCB54828) is announced by Incyte. It is a selective fibroblast growth factor receptor inhibitor in comparison to cisplatin with gemcitabine chemotherapy, which is the current treatment for patients with surgically unresectable or metastatic cholangiocarcinoma.

Most of the patients with cholangiocarcinoma do not effectively respond to currently available treatment and it cannot be surgically removed. Therefore, there is a requirement to develop new treatment options and FIGHT-302 is one of them.

Cholangiocarcinoma is a bile duct cancer, which is often identified during late stages (stage III and IV). It has a poor prognosis and is most common in individuals with more than 70 years age.

Progression free survival evaluated by independent review is the primary endpoint for FIGHT-302. Response duration, safety and quality of life impact, overall survival, disease control rate and overall response rate are its secondary endpoints.


For further enquiries, write to or call us on:
info@igmpiindia.org/ +91 8587838177, +91 8130924488, 0120-2427175

Pharmaceuticals | Food | Clinical Research | Healthcare | Medical Coding | Medical Device | Nanotechnology | IPR

Placement testimonials: Our alumni are working with Fortune 500 and global Pharmaceutical, Food and healthcare giants like